| Trial ID: | L0603 |
| Source ID: | ChiCTR-IPR-15007014
|
| Associated Drug: |
Rosuvastatin
|
| Title: |
Effect of Rosuvastatin (10mg/d) treatment of Nonalcoholic fatty liver disease (NAFLD) patients with Metabolic Syndrome (MS) but without diabetes evaluated by 1H-MRS
|
| Acronym: |
--
|
| Status: |
Recruiting
|
| Study Results: |
No Results Available
|
| Results: |
--
|
| Conditions: |
Nonalcoholic fatty liver disease(NAFLD)
|
| Interventions: |
2:rosuvastatin (10mg/d) * 52 weeks;
|
| Outcome Measures: |
intrahepatocellular lipid (IHCL);nan
|
| Sponsor/Collaborators: |
Department of Endocrinology, Key Laboratory of Endocrinology, Ministry of Health, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences
|
| Gender: |
All
|
| Age: |
1870
|
| Phases: |
Phase 1
|
| Enrollment: |
2:20;
|
| Study Type: |
Interventional study
|
| Study Designs: |
Randomized parallel controlled trial
|
| Start Date: |
05/09/2015
|
| Completion Date: |
--
|
| Results First Posted: |
--
|
| Last Update Posted: |
18 April 2017
|
| Locations: |
China
|
| URL: |
http://www.chictr.org.cn/showproj.aspx?proj=11817
|
